GB1403264A - Sulphamoyl-pyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activity - Google Patents

Sulphamoyl-pyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activity

Info

Publication number
GB1403264A
GB1403264A GB4604672A GB4604672A GB1403264A GB 1403264 A GB1403264 A GB 1403264A GB 4604672 A GB4604672 A GB 4604672A GB 4604672 A GB4604672 A GB 4604672A GB 1403264 A GB1403264 A GB 1403264A
Authority
GB
United Kingdom
Prior art keywords
sulphamoyl
carbon atom
blood sugar
asymmetric carbon
sugar lowering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4604672A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of GB1403264A publication Critical patent/GB1403264A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
GB4604672A 1971-10-05 1972-10-05 Sulphamoyl-pyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activity Expired GB1403264A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2150279A DE2150279C2 (en) 1971-10-05 1971-10-05 Blood sugar lowering sulfamoylpyrimidines with an asymmetric carbon atom

Publications (1)

Publication Number Publication Date
GB1403264A true GB1403264A (en) 1975-08-28

Family

ID=5821847

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4604672A Expired GB1403264A (en) 1971-10-05 1972-10-05 Sulphamoyl-pyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activity

Country Status (13)

Country Link
JP (1) JPS4844272A (en)
AT (1) AT319952B (en)
CA (1) CA977755A (en)
CH (1) CH568982A5 (en)
DD (1) DD103442A6 (en)
DE (1) DE2150279C2 (en)
DK (1) DK136034C (en)
GB (1) GB1403264A (en)
IL (1) IL40514A (en)
NL (1) NL7213535A (en)
NO (1) NO133138C (en)
SE (1) SE385213B (en)
ZA (1) ZA727126B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521604A (en) * 1981-05-14 1985-06-04 Basf Aktiengesellschaft Heterocyclic dihaloacetamides, and herbicides which contain acetanilides as herbicidal active ingredients and the dihaloacetamides as antagonistic agents
WO2007120729A2 (en) * 2006-04-12 2007-10-25 Merck & Co., Inc. Pyridyl amide t-type calcium channel antagonists
US8637513B2 (en) 2007-10-24 2014-01-28 Merck Sharp & Dohme Corp. Heterocycle phenyl amide T-type calcium channel antagonists

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201625588A (en) * 2014-11-05 2016-07-16 第一三共股份有限公司 Cyclic amine derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695855C3 (en) * 1967-12-30 1979-07-12 Schering Ag, 1000 Berlin Und 4619 Bergkamen 4- (5-Isobutyl-2-pyrimidinyl) -sulfonamidophenylacetic acid- (2-methoxy-5-chloroanilide) and its salts with physiologically compatible bases
JPS5516143A (en) * 1978-07-18 1980-02-04 Yoshihisa Horikoshi Spindle

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521604A (en) * 1981-05-14 1985-06-04 Basf Aktiengesellschaft Heterocyclic dihaloacetamides, and herbicides which contain acetanilides as herbicidal active ingredients and the dihaloacetamides as antagonistic agents
WO2007120729A2 (en) * 2006-04-12 2007-10-25 Merck & Co., Inc. Pyridyl amide t-type calcium channel antagonists
WO2007120729A3 (en) * 2006-04-12 2008-01-03 Merck & Co Inc Pyridyl amide t-type calcium channel antagonists
US7875636B2 (en) 2006-04-12 2011-01-25 Merck Sharp & Dohme Corp. Pyridyl amide T-type calcium channel antagonists
AU2007238755B2 (en) * 2006-04-12 2012-07-12 Merck Sharp & Dohme Llc Pyridyl amide T-type calcium channel antagonists
US8263627B2 (en) 2006-04-12 2012-09-11 Merck Sharp & Dohme Corp. Pyridyl amide T-type calcium channel antagonists
US8637513B2 (en) 2007-10-24 2014-01-28 Merck Sharp & Dohme Corp. Heterocycle phenyl amide T-type calcium channel antagonists

Also Published As

Publication number Publication date
JPS4844272A (en) 1973-06-26
DK136034B (en) 1977-08-01
DE2150279A1 (en) 1973-04-12
AU4735672A (en) 1974-04-11
IL40514A (en) 1976-12-31
ZA727126B (en) 1973-06-27
CH568982A5 (en) 1975-11-14
DE2150279C2 (en) 1983-08-25
CA977755A (en) 1975-11-11
NL7213535A (en) 1973-04-09
IL40514A0 (en) 1972-12-29
SE385213B (en) 1976-06-14
DD103442A6 (en) 1974-01-20
AT319952B (en) 1975-01-27
NO133138C (en) 1976-03-17
DK136034C (en) 1978-01-23
NO133138B (en) 1975-12-08

Similar Documents

Publication Publication Date Title
AU4916272A (en) Catheter and cannula assembly
CA1013638A (en) Catheter placement unit
AU4583472A (en) Medical procedure tray
ZA722405B (en) Blood collecting assembly
CA999203A (en) Body-retained catheter
IL45786A0 (en) Heart activity detector
ZA721704B (en) Heart valve
CA1002412A (en) Infusion cannula assemblies
IL45836A (en) Blood oxygenator
ZA72277B (en) Insulin derivatives
CA952825A (en) Stethoscope
GB1403264A (en) Sulphamoyl-pyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activity
CA951247A (en) Selective frequency stethoscope structure
IL36704A (en) Sulphamoylpyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activity
AU483774B2 (en) Sulphamoyl-pyrimidines containing an asymmetric 1 carbon atom and having a blood sugar lowering activity
KE2813A (en) 17-hydroxy-7-(lower alkokxy) carbonyl-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid ypsilon-lactones and congeners
AU4598872A (en) Heart pacemaker
CA992068A (en) Steroid having anaesthetic activity
AU449036B2 (en) Sulphamoylphrimidines containing an asymmetric carbon atom and having a bloo sugar lowering activity
AU2839071A (en) Sulphamoylphrimidines containing an asymmetric carbon atom and having a bloo sugar lowering activity
GB1374720A (en) Heart pacers
CA904298A (en) Blood sugar lowering sulphamoylpyrimidines containing an asymmetric carbon atom
ZA724184B (en) Stabilized blood composition
ZA727443B (en) New blood sugar-sinking sulphonylaminopyrimidines and the preparation thereof
CA866544A (en) Catheter placement unit

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee